Grants and Contributions

The objective of this funding opportunity is to catalyze and support research efforts of Canadian researchers to use the available CLSA data in order to better understand how (individually and in combination) the biological, medical, psychological, social, lifestyle and/or economic aspects of people’s lives have an impact in both maintaining health and in the development of disease and disability as people age.

• The CIHR Institute of Musculoskeletal Health and Arthritis (CIHR-IMHA) will fund applications that are determined to be relevant to the mandate and research priority areas of CIHR-IMHA as described below:
o Skin Health

The objective of this funding opportunity is to catalyze and support research efforts of Canadian researchers to use the available CLSA data in order to better understand how (individually and in combination) the biological, medical, psychological, social, lifestyle and/or economic aspects of people’s lives have an impact in both maintaining health and in the development of disease and disability as people age.

• The CIHR Institute of Musculoskeletal Health and Arthritis (CIHR-IMHA) will fund applications that are determined to be relevant to the mandate and research priority areas of CIHR-IMHA as described below:
o Musculoskeletal Health (arthritis, musculoskeletal rehabilitation, bone, skeletal muscle)

The “Catalyst Grant: Addressing Musculoskeletal Conditions and Arthritis in Canadians” is expected to:
•Support original, high quality projects that have the potential to generate innovative research, research tools, techniques, devices, inventions, or methods that will translate into a clinical or health services improvement for Canadians within 5-7 years;
•Facilitate team formation and build patient-oriented research capacity by encouraging partnerships amongst patients, patient communities, patient organizations and health charities, researchers, health care professionals and health system decision makers or policy makers;
•Generate preliminary observations, data or knowledge to stimulate research in areas where there is a substantial burden of disease in musculoskeletal conditions and arthritis in Canada, as identified by the respective communities.

• The CIHR Institute of Nutrition, Metabolism and Diabetes (INMD) will provide funding for an application determined to be relevant to the broad INMD mandate as described below:
o CIHR-INMD supports research to enhance health in relation to diet, digestion, excretion, and metabolism; and to address causes, prevention, screening, diagnosis, treatment, support systems, and palliation for a wide range of conditions and problems associated with hormone, digestive system, kidney, and liver.
• These grants afford principal investigators an opportunity to resubmit their research proposal without the loss of momentum, staff or trainees.

.
• As a partner in SPOR, CIHR will provide bridge funding for fundable applications that are below the competition funding cut-off and aligned with the SPOR vision and the SPOR Patient Engagement Framework. Categories are described in the Funds Available section.

The Operating Grant: Methamphetamine and related psychostimulant use is expected to:

• Generate new knowledge around prevalence, incidence, and distribution of methamphetamine use in Canada
• Increase the uptake and application of synthesized knowledge in evidence-based decision-making, health care and/or health services policy and practice in this space
• Support partnerships between researchers and knowledge users to rapidly inform policies related to prevention, harm reduction, and treatment of methamphetamine use
• Address the pressing intervention-related evidence needs of knowledge users in this space
• Encourage implementation science approaches that consider sub-populations and/or the biological and social determinants of methamphetamine use

• The CIHR Institute of Musculoskeletal Health and Arthritis (CIHR-IMHA) will fund applications that are determined to be relevant to the mandate and research priority areas of CIHR-IMHA as described below:
o Skin Health

The “Catalyst Grant: Addressing Musculoskeletal Conditions and Arthritis in Canadians” is expected to:

• Support original, high quality projects that have the potential to generate innovative research, research tools, techniques, devices, inventions, or methods that will translate into a clinical or health services improvement for Canadians within 5-7 years;
• Facilitate team formation and build patient-oriented research capacity by encouraging partnerships amongst patients, patient communities, patient organizations and health charities, researchers, health care professionals and health system decision makers or policy makers;
• Generate preliminary observations, data or knowledge to stimulate research in areas where there is a substantial burden of disease in musculoskeletal conditions and arthritis in Canada, as identified by the respective communities.